(Q34224183)

31 July 2017

1 reference

title

Multiple sclerosis: current pathophysiological concepts (English)

1 reference

31 July 2017

0 references

1 reference

Wingerchuk DM

1

1 reference

31 July 2017

Lucchinetti CF

series ordinal

2

1 reference

31 July 2017

Noseworthy JH

series ordinal

3

1 reference

31 July 2017

publication date

1 March 2001

1 reference

31 July 2017

published in

Laboratory Investigation

1 reference

31 July 2017

volume

81

1 reference

31 July 2017

issue

3

1 reference

31 July 2017

page(s)

263-281

1 reference

Functional diversity of helper T lymphocytes

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

The N-terminal domain of the myelin oligodendrocyte glycoprotein (MOG) induces acute demyelinating experimental autoimmune encephalomyelitis in the Lewis rat

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Rescue of mammary epithelial cell apoptosis and entactin degradation by a tissue inhibitor of metalloproteinases-1 transgene

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

The B7-CD28/CTLA-4 costimulatory pathways in autoimmune disease of the central nervous system

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Inhibition of experimental autoimmune encephalomyelitis by an antibody to the intercellular adhesion molecule ICAM-1.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

The role of integrins in immune-mediated diseases of the nervous system

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

A monoclonal autoantibody which promotes central nervous system remyelination is highly polyreactive to multiple known and novel antigens

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Presentation of alpha B-crystallin to T cells in active multiple sclerosis lesions: an early event following inflammatory demyelination

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

The longstanding MS lesion. A quantitative MRI and electron microscopic study

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Surface expression of alpha 4 integrin by CD4 T cells is required for their entry into brain parenchyma

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis: do cytokines trigger off exacerbations?

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Myelin oligodendrocyte glycoprotein: a novel candidate autoantigen in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Failure to detect Chlamydia pneumoniae in the central nervous system of patients with MS.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Microbial peptides and superantigens in the pathogenesis of autoimmune diseases of the central nervous system

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Monocyte/macrophage differentiation in early multiple sclerosis lesions

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

The adhesion molecule and cytokine profile of multiple sclerosis lesions

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Differential adhesion molecule requirements for immune surveillance and inflammatory recruitment

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Molecular mechanisms of anti-inflammatory action of glucocorticoids

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Plaque-associated expression of human herpesvirus 6 in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Matrix metalloproteinases degrade myelin basic protein

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Matrix metalloproteinases, tumor necrosis factor and multiple sclerosis: an overview

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

The genetics of multiple sclerosis: principles, background and updated results of the United Kingdom systematic genome screen

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Neuronal death in the hippocampus is promoted by plasmin-catalyzed degradation of laminin

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Matrix metalloproteinase expression during experimental autoimmune encephalomyelitis and effects of a combined matrix metalloproteinase and tumour necrosis factor-alpha inhibitor

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Defective T cell Fas function in patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Induction of Th1 and Th2 CD4+ T cell responses: the alternative approaches

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Inducible nitric oxide synthase gene expression and enzyme activity correlate with disease activity in murine experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Evidence for the production of peroxynitrite in inflammatory CNS demyelination

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

The Expression of Tissue-type Plasminogen Activator, Matrix Metalloproteases and Endogenous Inhibitors in the Central Nervous System in Multiple Sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Mechanisms of anti-inflammatory action and of immunosuppression by glucocorticoids: negative interference of activated glucocorticoid receptor with transcription factors

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

In vivo evidence for axonal dysfunction remote from focal cerebral demyelination of the type seen in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Multiple sclerosis: Fas signaling in oligodendrocyte cell death

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Resistance of young gelatinase B-deficient mice to experimental autoimmune encephalomyelitis and necrotizing tail lesions.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Immunological profile of patients with primary progressive multiple sclerosis. Expression of adhesion molecules

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

A population-based study of multiple sclerosis in twins

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

A full genome search in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

A genetic basis for familial aggregation in multiple sclerosis. Canadian Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Immunoglobulin-containing cells in multiple-sclerosis plaques

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Association of the APOE epsilon4 allele with disease activity in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Axonal damage in acute multiple sclerosis lesions

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Comparison of triple dose versus standard dose gadolinium-DTPA for detection of MRI enhancing lesions in patients with MS.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Peripheral blood ?-? T cells lyse fresh human brain?Derived oligodendrocytes

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

The application of multifactorial cluster analysis in the staging of plaques in early multiple sclerosis. Identification and characterization of the primary demyelinating lesion

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Identification of autoantibodies associated with myelin damage in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Reversal of experimental autoimmune encephalomyelitis with a hydroxamate inhibitor of matrix metalloproteases

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Chlamydia: a role for multiple sclerosis or more confusion?

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Longitudinal study of soluble adhesion molecules in multiple sclerosis: correlation with gadolinium enhanced magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Immunohistochemical studies of adult human glial cells

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

The significance of perivascular infiltrations in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

A complete genomic screen for multiple sclerosis underscores a role for the major histocompatability complex. The Multiple Sclerosis Genetics Group

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Probing degeneracy in T-cell recognition using peptide combinatorial libraries

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

The neuroprotective effect of inflammation: implications for the therapy of multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Apoptosis mediators fasL and TRAIL are upregulated in peripheral blood mononuclear cells in MS

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

A metalloprotease-disintegrin, MDC9/meltrin-gamma/ADAM9 and PKCdelta are involved in TPA-induced ectodomain shedding of membrane-anchored heparin-binding EGF-like growth factor.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Cytokine-induced modulation of cellular adhesion to human cerebral endothelial cells is mediated by soluble vascular cell adhesion molecule-1

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation?

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Effector pathways in immune mediated central nervous system demyelination

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

In vivo expression of inducible nitric oxide synthase in experimentally induced neurologic diseases

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Genomewide scan of multiple sclerosis in Finnish multiplex families

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Myelin basic protein-specific T helper 2 (Th2) cells cause experimental autoimmune encephalomyelitis in immunodeficient hosts rather than protect them from the disease

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Immunopathology of multiple sclerosis: report on an international meeting held at the Institute of Neurology of the University of Vienna.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Ecologic studies of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Serum gelatinase B, TIMP-1 and TIMP-2 levels in multiple sclerosis. A longitudinal clinical and MRI study

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Matrix metalloproteinase-9 (gelatinase B) is selectively elevated in CSF during relapses and stable phases of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Effective treatment of models of multiple sclerosis by matrix metalloproteinase inhibitors.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Progressive cerebral atrophy in multiple sclerosis. A serial MRI study

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Axonal changes in chronic demyelinated cervical spinal cord plaques

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Defining the clinical course of multiple sclerosis: Results of an international survey

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Distinct patterns of multiple sclerosis pathology indicates heterogeneity on pathogenesis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 113 cases

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Chemokines--chemotactic cytokines that mediate inflammation

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Matrix metalloproteinases in the normal human central nervous system, microglial nodules, and multiple sclerosis lesions

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Absence of seven human herpesviruses, including HHV-6, by polymerase chain reaction in CSF and blood from patients with multiple sclerosis and optic neuritis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Proinflammatory cytokines regulate antigen-independent T-cell activation by two separate calcium-signaling pathways in multiple sclerosis patients.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Immunopathogenesis of multiple sclerosis: the role of T cells

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

A very high level of crossreactivity is an essential feature of the T-cell receptor

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Serum soluble adhesion molecules in multiple sclerosis: raised sVCAM-1, sICAM-1 and sE-selectin in primary progressive disease

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Malignant monophasic multiple sclerosis or "Marburg's disease"

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Oligodendrocyte and axon pathology in clinically silent multiple sclerosis lesions

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Absence of human herpesvirus 6 and 7 from spinal fluid and serum of multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

The British Isles survey of multiple sclerosis in twins

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Perforin-dependent neurologic injury in a viral model of multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Immunoglobulin G Fc-receptor (FcgammaR) IIA and IIIB polymorphisms related to disability in MS

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Review: cytokines and the pathogenesis of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Progress in determining the causes and treatment of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

1 reference

7 January 2021

IV immunoglobulin does not reverse established weakness in MS.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Cytokines induce the development of functionally heterogeneous T helper cell subsets

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Expression of the inducible isoform of nitric oxide synthase in the central nervous system of mice correlates with the severity of actively induced experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Aminoguanidine, a selective inhibitor of the inducible nitric oxide synthase, has different effects on experimental allergic encephalomyelitis in the induction and progression phase

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Regulatory CD4(+) T cells expressing endogenous T cell receptor chains protect myelin basic protein-specific transgenic mice from spontaneous autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Repertoire requirements of CD4+ T cells that prevent spontaneous autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Exacerbations of multiple sclerosis in patients treated with gamma interferon

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Glutamate excitotoxicity in a model of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Interferon-gamma modulates human oligodendrocyte susceptibility to Fas-mediated apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

The Dale E. McFarlin Memorial Lecture: the immunology of the multiple sclerosis lesion

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Demyelination in primate autoimmune encephalomyelitis and acute multiple sclerosis lesions: a case for antigen-specific antibody mediation

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Implantation of stimulated homologous macrophages results in partial recovery of paraplegic rats.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Antibodies to the axolemma-enriched fraction in the cerebrospinal fluid and serum of patients with multiple sclerosis and other neurological diseases

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Nitric oxide donors reversibly block axonal conduction: demyelinated axons are especially susceptible

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Immunoglobulins promote remyelination in the central nervous system

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Immunosuppression promotes CNS remyelination in chronic virus‐induced demyelinating disease

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Ultrastructure of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Immunoglobulins reactive with myelin basic protein promote CNS remyelination

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

1 reference

7 January 2021

A population-based study of multiple sclerosis in twins: update.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Association of interleukin-1beta and interleukin-1 receptor antagonist genes with disease severity in MS

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Colocalization of lymphocytes bearing gamma delta T-cell receptor and heat shock protein hsp65+ oligodendrocytes in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

A putative mechanism of demyelination in multiple sclerosis by a proteolytic enzyme, calpain

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

More mayhem from molecular mimics

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Multiple sclerosis: in situ evidence for antibody- and complement-mediated demyelination

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Nerve growth factor is an autocrine survival factor for memory B lymphocytes.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Axonal transection in the lesions of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Autoreactive CD8+ T-cell responses to human myelin protein-derived peptides

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Migratory behavior of lymphocytes isolated from multiple sclerosis patients: effects of interferon beta-1b therapy

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Antigen-independent activation of naive and memory resting T cells by a cytokine combination

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Extensive peroxynitrite activity during progressive stages of central nervous system inflammation

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Promotion of remyelination by polyclonal immunoglobulin in Theiler's virus-induced demyelination and in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

The small heat-shock protein αB-crystallin as candidate autoantigen in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Major histocompatibility complex class II alleles and the course and outcome of MS: a population-based study

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

The degradation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromelysin, collagenase, plasmin, and heparanases

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

The clinical course of neuromyelitis optica (Devic's syndrome).

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Structural and Functional Aspects of the Interaction of Inflammatory Cells with the Blood-Brain Barrier in Experimental Brain Inflammation

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Chronic stage multiple sclerosis lesions contain a relatively quiescent population of oligodendrocyte precursor cells

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Interferon beta in the treatment of multiple sclerosis: mechanisms of action

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Matrix metalloproteinases and diseases of the CNS.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

Aberrant T cell migration toward RANTES and MIP-1 alpha in patients with multiple sclerosis. Overexpression of chemokine receptor CCR5.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780235

7 January 2021

10.1038/LABINVEST.3780235

Identifiers

DOI

1 reference

Dimensions Publication ID

31 July 2017

1028032986

0 references

1 reference